These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 25548481)

  • 1. Dendritic cells in hepatitis C virus infection: key players in the IFNL3-genotype response.
    O'Connor KS; George J; Booth D; Ahlenstiel G
    World J Gastroenterol; 2014 Dec; 20(47):17830-8. PubMed ID: 25548481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFNL3 mediates interaction between innate immune cells: Implications for hepatitis C virus pathogenesis.
    O'Connor KS; Ahlenstiel G; Suppiah V; Schibeci S; Ong A; Leung R; van der Poorten D; Douglas MW; Weltman MD; Stewart GJ; Liddle C; George J; Booth DR
    Innate Immun; 2014 Aug; 20(6):598-605. PubMed ID: 24045339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum IFN-λ3 Levels Correlate with Serum Hepatitis C Virus RNA Levels in Symptomatic Patients with Acute Hepatitis C.
    Imoto S; Kim SR; Amano K; Iio E; Yoon S; Hirohata S; Yano Y; Ishikawa T; Katsushima S; Komeda T; Fukunaga T; Chung H; Kokuryu H; Horie Y; Hatae T; Fujinami A; Kim SK; Kudo M; Tanaka Y
    Dig Dis; 2017; 35(6):531-540. PubMed ID: 29040985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate and adaptive genetic pathways in HCV infection.
    Buchanan R; Hydes T; Khakoo SI
    Tissue Antigens; 2015 Apr; 85(4):231-40. PubMed ID: 25708172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFNL3 genotype is associated with differential induction of IFNL3 in primary human hepatocytes.
    Kurbanov F; Kim Y; Latanich R; Chaudhari P; El-Diwany R; Knabel M; Kandathil AJ; Cameron A; Cox A; Jang YY; Thomas DL; Balagopal A
    Antivir Ther; 2015; 20(8):805-14. PubMed ID: 26109548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indolamine 2,3-dioxygenase expression by monocytes and dendritic cell populations in hepatitis C patients.
    Schulz S; Landi A; Garg R; Wilson JA; van Drunen Littel-van den Hurk S
    Clin Exp Immunol; 2015 Jun; 180(3):484-98. PubMed ID: 25605587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host-virus interactions in hepatitis B and hepatitis C infection.
    Yoshio S; Kanto T
    J Gastroenterol; 2016 May; 51(5):409-20. PubMed ID: 26894594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient virus assembly, but not infectivity, determines the magnitude of hepatitis C virus-induced interferon alpha responses of plasmacytoid dendritic cells.
    Grabski E; Wappler I; Pfaender S; Steinmann E; Haid S; Dzionek A; Pietschmann T; Kalinke U
    J Virol; 2015 Mar; 89(6):3200-8. PubMed ID: 25552725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In HIV/HCV coinfected patients dendritic cell activation state is not associated with IL28B genotype.
    Sacchi A; Lapa D; Garbuglia AR; Taibi C; Tumino N; D'Offizi G; Martini F
    J Infect Dis; 2013 Jul; 208(2):364-5. PubMed ID: 23570849
    [No Abstract]   [Full Text] [Related]  

  • 10. Human blood dendritic cell antigen 3 (BDCA3)(+) dendritic cells are a potent producer of interferon-λ in response to hepatitis C virus.
    Yoshio S; Kanto T; Kuroda S; Matsubara T; Higashitani K; Kakita N; Ishida H; Hiramatsu N; Nagano H; Sugiyama M; Murata K; Fukuhara T; Matsuura Y; Hayashi N; Mizokami M; Takehara T
    Hepatology; 2013 May; 57(5):1705-15. PubMed ID: 23213063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs.
    McFarland AP; Horner SM; Jarret A; Joslyn RC; Bindewald E; Shapiro BA; Delker DA; Hagedorn CH; Carrington M; Gale M; Savan R
    Nat Immunol; 2014 Jan; 15(1):72-9. PubMed ID: 24241692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IPS-1 is essential for type III IFN production by hepatocytes and dendritic cells in response to hepatitis C virus infection.
    Okamoto M; Oshiumi H; Azuma M; Kato N; Matsumoto M; Seya T
    J Immunol; 2014 Mar; 192(6):2770-7. PubMed ID: 24532585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection.
    Eslam M; Leung R; Romero-Gomez M; Mangia A; Irving WL; Sheridan D; Spengler U; Mollison L; Cheng W; Bugianesi E; McLeod D; Zaitoun AM; Attino V; Goeltz D; Nattermann J; Douglas M; Booth DR; George J; Ahlenstiel G
    J Hepatol; 2014 Aug; 61(2):235-41. PubMed ID: 24768758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered effector functions of NK cells in chronic hepatitis C are associated with IFNL3 polymorphism.
    Rogalska-Taranta M; Markova AA; Taranta A; Lunemann S; Schlaphoff V; Flisiak R; Manns MP; Cornberg M; Kraft AR; Wedemeyer H
    J Leukoc Biol; 2015 Aug; 98(2):283-94. PubMed ID: 26034208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organ system view of the hepatic innate immunity in HCV infection.
    Bang BR; Elmasry S; Saito T
    J Med Virol; 2016 Dec; 88(12):2025-2037. PubMed ID: 27153233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of hepatic innate immunity by hepatitis C virus.
    Horner SM; Gale M
    Nat Med; 2013 Jul; 19(7):879-88. PubMed ID: 23836238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.
    Vergara C; Thio CL; Johnson E; Kral AH; O'Brien TR; Goedert JJ; Mangia A; Piazzolla V; Mehta SH; Kirk GD; Kim AY; Lauer GM; Chung RT; Cox AL; Peters MG; Khakoo SI; Alric L; Cramp ME; Donfield SM; Edlin BR; Busch MP; Alexander G; Rosen HR; Murphy EL; Latanich R; Wojcik GL; Taub MA; Valencia A; Thomas DL; Duggal P
    Gastroenterology; 2019 Apr; 156(5):1496-1507.e7. PubMed ID: 30593799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: the InC(3) study.
    Hajarizadeh B; Grady B; Page K; Kim AY; McGovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Schinkel J; Applegate T; Maher L; Hellard M; Lloyd AR; Prins M; Geskus RB; Dore GJ; Grebely J;
    J Clin Virol; 2014 Nov; 61(3):430-4. PubMed ID: 25256151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained hyperresponsiveness of dendritic cells is associated with spontaneous resolution of acute hepatitis C.
    Pelletier S; Bédard N; Said E; Ancuta P; Bruneau J; Shoukry NH
    J Virol; 2013 Jun; 87(12):6769-81. PubMed ID: 23576504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness.
    Sheahan T; Imanaka N; Marukian S; Dorner M; Liu P; Ploss A; Rice CM
    Cell Host Microbe; 2014 Feb; 15(2):190-202. PubMed ID: 24528865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.